GeoffreyAndrewWalfordMD
Endocrinology • Boston, MADiabetes, Lipid Metabolism, Clinical Pharmacology
Senior Principal Scientist, Merck
Dr. Walford is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Merck Research Laboratories
33 Avenue Louis Pasteur
Boston, MA 02115- Is this information wrong?
Education & Training
Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2008 - 2011
Brigham and Women's HospitalResidency, Internal Medicine, 2005 - 2008
Geisel School of Medicine at DartmouthClass of 2005
Certifications & Licensure
MA State Medical License 2007 - 2025
Publications & Presentations
PubMed
- Author Correction: Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists.Wu, M., Carballo-Jane, E., Zhou, H., Zafian, P., Dai, G., Liu, M., Lao, J., Kelly, T., Shao, D., Gorski, J., Pissarnitski, D., Kekec, A., Chen, Y., Previs, S., Scapin,...> ;Nature Communications. 2024 Jan 23
- Pooled analysis of routine safety parameters observed in healthy participants at baseline and following placebo administration in early phase clinical studies.Kelly E Duncan, Runcheng Li, Lata Maganti, Amit Kumar, S Aubrey Stoch, Geoffrey A Walford> ;Clinical and Translational Science. 2024 Jan 1
- 1 citationsConsiderations for Cell and Gene Therapy Programs Entering the Clinical Space.Geoffrey A Walford, An Bautmans, Carol Cannon, Kelly E Duncan, Kathleen Deschamps, Randolph P Matthews, Jesse Nussbaum, S Aubrey Stoch> ;Clinical Pharmacology and Therapeutics. 2023 Sep 1
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
